Marzulene-S


Indications and Reactions:

Role Indications Reactions
Secondary
Prophylaxis 28.5%
Acute Lymphocytic Leukaemia 18.5%
Dyspnoea 9.2%
Rheumatoid Arthritis 6.9%
Gastritis 5.4%
Interstitial Lung Disease 4.6%
Antiemetic Supportive Care 2.3%
Cholelithiasis 2.3%
Colon Cancer Metastatic 2.3%
Gastritis Prophylaxis 2.3%
Hypercholesterolaemia 2.3%
Hypertension 2.3%
Insomnia 2.3%
Lumbar Spinal Stenosis 2.3%
Thromboangiitis Obliterans 2.3%
Upper Respiratory Tract Inflammation 2.3%
Emphysema 1.5%
Abdominal Pain Upper 0.8%
Convulsion 0.8%
Decreased Appetite 0.8%
Interstitial Lung Disease 25.0%
Upper Respiratory Tract Inflammation 25.0%
Hepatic Function Abnormal 16.7%
White Blood Cell Count Decreased 16.7%
Drug Reaction With Eosinophilia And Systemic Symptoms 8.3%
Pneumocystis Jiroveci Pneumonia 8.3%
Concomitant
Rheumatoid Arthritis 22.4%
Prophylaxis 12.7%
Hypertension 8.2%
Gastritis 7.3%
Drug Use For Unknown Indication 6.3%
Product Used For Unknown Indication 6.3%
Hepatitis C 6.1%
Chronic Hepatitis C 4.8%
Constipation 4.3%
Osteoporosis 3.6%
Diabetes Mellitus 2.8%
Insomnia 2.7%
Gastric Ulcer 2.0%
Hyperlipidaemia 1.9%
Depression 1.7%
Multiple Myeloma 1.7%
Cancer Pain 1.6%
Castleman's Disease 1.4%
Herpes Zoster 1.2%
Antibiotic Prophylaxis 1.0%
White Blood Cell Count Decreased 17.3%
White Blood Cell Count Increased 7.7%
Platelet Count Decreased 6.4%
Pleural Effusion 5.1%
Vomiting 5.1%
Haemoglobin Decreased 4.5%
Pneumonia 4.5%
Pyrexia 4.5%
Renal Impairment 4.5%
Urinary Tract Infection 4.5%
Disseminated Tuberculosis 3.8%
Hepatic Function Abnormal 3.8%
Hypoglycaemia 3.8%
Rash 3.8%
Renal Failure Acute 3.8%
Rhabdomyolysis 3.8%
Anaemia 3.2%
Delirium 3.2%
Drug Eruption 3.2%
Liver Disorder 3.2%

Drug Data